SORIN VVR 4000I AND 4000I SMARXT FILTERED HARDSHELL VENOUS RESERVOIR 050556

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional report with the FDA on 2016-10-03 for SORIN VVR 4000I AND 4000I SMARXT FILTERED HARDSHELL VENOUS RESERVOIR 050556 manufactured by Sorin Group Italia Srl.

Event Text Entries

[56307440] Patient information was not provided. The vvr4000i smarxt hp reservoir (lot number 1602050118) is a non-sterile device that was assembled into a convenience pack (catalog 084118102, lot 1616500047 or 1617400034) and sterilized before distribution and use in the usa. Expiration date (mm/dd/yyyy) for both convenience pack lots: 06/30/2018. Unique identifier (udi) number for the convenience packs: lot 1616500047 - (b)(4). Lot 1617400034 - (b)(4). Device manufacture date (mm/dd/yyyy) for the convenience packs: lot 1616500047 - 06/13/2016. Lot 1617400034 - 06/22/2016. The sorin vvr 4000i smarxt was assembled into a convenience pack distributed in usa. The non-sterile reservoir is also distributed in the usa as a sterile device (510(k)number: k092315). Sorin group (b)(4) manufactures the sorin vvr 4000i smarxt hardshell venous reservoir. The incident occurred in (b)(6). (b)(4). Sorin group (b)(4) received a report that, during a procedure, the blue cap on the cardiotomy port was blown off due to over-pressurization of the sorin vvr 4000i smarxt hardshell venous reservoir. Blood and foam were sprayed in the operation room. The reservoir was changed out and the bypass was re-initiated. Reportedly the event occurred while the patient was off by-pass. At the end of the procedure, the patient was put in ecmo and transferred in icu. The patient died after the procedure. The cause of death is unknown, however the perfusionist has stated that it is not believed the outcome of the patient is associated with the failure of the device. The device has been returned to sorin group (b)(4) and the investigation is in progress. A follow-up report will be sent when the investigation has been completed. Device returned, not yet decontaminated.
Patient Sequence No: 1, Text Type: N, H10


[56307441] Sorin group (b)(4) received a report that, during a procedure, the blue cap on the cardiotomy port was blown off due to over-pressurization of the sorin vvr 4000i smarxt hardshell venous reservoir. Blood and foam were sprayed in the operation room. The reservoir was changed out and the bypass was re-initiated. Reportedly the event occurred while the patient was off by-pass. At the end of the procedure, the patient was put in ecmo and transferred in icu. The patient died after the procedure. The cause of death is unknown, however the perfusionist has stated that it is not believed the outcome of the patient is associated with the failure of the device.
Patient Sequence No: 1, Text Type: D, B5


[65276643] Sorin group (b)(4) manufactures the sorin vvr 4000i smarxt hardshell venous reservoir. The incident occurred in (b)(6). Visual inspection of the reservoir at sorin group usa identified residual blood still inside the unit. No defects or abnormalities were detected. The device was returned to sorin group (b)(4) for further investigation, where simulated use testing found that the cardiotomy filter of the reservoir was partially occluded by clotted blood or biological material from the surgical field. However, no non conformities were noted during the control and testing phases. Sorin group (b)(4) has concluded that the most probable root cause of the event is associated with the filtration clotting phenomenon triggered by multiple factors such as patient blood features, clinical procedure and use condition. The use of co2 during the procedure, as described by the customer, can also trigger aggregate phenomena. Additionally, prolonged use of the device is not recommended per the instructions for use (ifu). Based on the pump sheet data for the event, the reservoir was used for 1. 5 hours longer than the recommended use time. A dhr review confirmed that the device was manufactured, tested and released in compliance with standard manufacturing procedures. According to traceability, no other complaints have been received for this lot. Based on the result of the investigation, no corrective action has been deemed necessary. Sorin group (b)(4) will continue to monitor for this type of issue.
Patient Sequence No: 1, Text Type: N, H10


[71335484] On march 6, 2017, sorin group (b)(4) learned that a user medwatch report ((b)(4)) was filed by the initial reporter for this event.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number9680841-2016-00500
MDR Report Key5993802
Report SourceHEALTH PROFESSIONAL
Date Received2016-10-03
Date of Report2017-03-30
Date of Event2016-09-03
Date Mfgr Received2017-03-06
Date Added to Maude2016-10-03
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactJOAN CEASAR
Manufacturer Street14401 W 65TH WAY
Manufacturer CityARVADA CO 80004
Manufacturer CountryUS
Manufacturer Postal80004
Manufacturer Phone2812287260
Manufacturer G1SORIN GROUP ITALIA S.R.L.
Manufacturer StreetSTRADA STATALE 12 NORD, 86
Manufacturer CityMIRANDOLA (MODENA) 41037
Manufacturer CountryIT
Manufacturer Postal Code41037
Single Use3
Remedial ActionOT
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameSORIN VVR 4000I AND 4000I SMARXT FILTERED HARDSHELL VENOUS RESERVOIR
Generic NameRESERVOIR, BLOOD, CARDIOPULMONARY BYPASS
Product CodeDTN
Date Received2016-10-03
Returned To Mfg2016-09-29
Catalog Number050556
Lot Number1602050118
OperatorHEALTH PROFESSIONAL
Device AvailabilityR
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerSORIN GROUP ITALIA SRL
Manufacturer AddressSTRADA STATALE 12 NORD, 86 MIRANDOLA (MODENA) US


Patients

Patient NumberTreatmentOutcomeDate
101. Death 2016-10-03

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.